|
Jenburkt Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
472.25 Cr.
|
P/BV
|
2.40
|
Book Value (Rs.)
|
446.47
|
|
52 Week High/Low (Rs.)
|
1340/944
|
FV/ML
|
10/1
|
P/E(X)
|
13.60
|
|
Bookclosure
|
11/07/2025
|
EPS (Rs.)
|
78.71
|
Div Yield (%)
|
1.93
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 168.74 | 151.37 | 141.63 | 136.14 | 123.73 |
| Other Operating Revenues | 0.00 | 0.33 | 0.33 | 0.61 | 0.25 |
| Total Operating Revenues | 168.74 | 151.69 | 141.97 | 136.75 | 123.98 |
| | | | | | |
| Other Income | 10.30 | 6.72 | 4.67 | 5.12 | 4.95 |
| Total Revenue | 179.04 | 158.41 | 146.63 | 141.87 | 128.93 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 8.99 | 8.51 | 8.39 | 11.12 | 11.74 |
| Purchase Of Stock-In Trade | 28.18 | 21.26 | 22.41 | 20.55 | 21.98 |
| Operating And Direct Expenses | 0.00 | 1.16 | 0.73 | 0.80 | 0.63 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -4.85 | -0.12 | -0.39 | 1.34 | -2.28 |
| Employee Benefit Expenses | 49.88 | 45.54 | 42.49 | 38.81 | 36.49 |
| Finance Costs | 0.46 | 0.45 | 0.27 | 0.37 | 0.43 |
| Depreciation And Amortisation Expenses | 3.11 | 2.73 | 2.34 | 2.26 | 1.90 |
| Other Expenses | 42.79 | 34.95 | 35.22 | 33.77 | 28.17 |
| Total Expenses | 128.57 | 114.48 | 111.46 | 109.01 | 99.06 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 50.47 | 43.93 | 35.18 | 32.86 | 29.87 |
| | | | | | |
| Exceptional Items | -3.95 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 46.52 | 43.93 | 35.18 | 32.86 | 29.87 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 11.78 | 11.90 | 9.64 | 8.56 | 7.35 |
| Deferred Tax | 0.00 | -0.21 | -0.52 | -0.23 | 0.30 |
| Tax For Earlier Years | 0.00 | 0.18 | 0.08 | -0.08 | -0.07 |
| Total Tax Expenses | 11.78 | 11.87 | 9.20 | 8.26 | 7.57 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 34.74 | 32.06 | 25.98 | 24.61 | 22.30 |
| | | | | | |
| Profit/Loss From Continuing Operations | 34.74 | 32.06 | 25.98 | 24.61 | 22.30 |
| | | | | | |
| Profit/Loss For The Period | 34.74 | 32.06 | 25.98 | 24.61 | 22.30 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 78.71 | 72.65 | 58.86 | 53.90 | 48.58 |
| Diluted EPS (Rs.) | 78.71 | 72.65 | 58.86 | 53.90 | 48.58 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 6.75 | 6.36 | 5.51 | 4.68 |
| Equity Dividend Rate (%) | 207.00 | 180.00 | 153.00 | 144.00 | 120.00 |
